CD274 and chronic obstructive pulmonary disease: The results showed that a statistically significant reduction in the number of PD-L1+ cDC1 cells was only seen in the patients with GOLD stage II COPD and not in the normal subjects (10.6 ± 10.8% vs. 32.5 ± 33.1%, respectively, p = 0.01, Figure 2B).